Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Chemoimmunotherapy”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Testing effectiveness (Phase 2)Looking for participantsNCT06845319
What this trial is testing

Anthracycline-Free Neoadjuvant Chemoimmunotherapy for Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Medical University of South Carolina 43
Not applicableNot Yet RecruitingNCT07092449
What this trial is testing

Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma

Who this might be right for
Gastroesophageal JunctionGastric / Gastroesophageal Junction AdenocarcinomaNeoadjuvant Chemoimmunotherapy+1 more
Tang-Du Hospital 30
Not applicableLooking for participantsNCT07478900
What this trial is testing

Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)Tattoo Skin MarkersNeoadjuvant Chemoimmunotherapy
All India Institute of Medical Sciences, Bhubaneswar 30
Early research (Phase 1)Not Yet RecruitingNCT07300475
What this trial is testing

Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Washington University School of Medicine 30
Not applicableStudy completedNCT06854107
What this trial is testing

Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

Who this might be right for
Pathologic Complete Response
Zilong Yuan 225
Large-scale testing (Phase 3)Looking for participantsNCT06907602
What this trial is testing

Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT06289062
What this trial is testing

Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer

Who this might be right for
Cervical CancerNeoadjuvant ChemoimmunotherapyFertility Preservation
Tongji Hospital 40
Early research (Phase 1)UnknownNCT05700955
What this trial is testing

Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
University of Louisville 30
Not applicableLooking for participantsNCT07063901
What this trial is testing

Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer

Who this might be right for
Esophagus Cancer
Central South University 200
Not applicableNot Yet RecruitingNCT07506889
What this trial is testing

Simplified Exercise-based Risk Assessment in Lung Cancer

Who this might be right for
Lung Cancer (Diagnosis)LobectomySurgery Complications+3 more
Linkoeping University 500
Not applicableActive Not RecruitingNCT06243679
What this trial is testing

The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC

Who this might be right for
Resectable/Potentially Resectable NSCLC
Xiangya Hospital of Central South University 100
Testing effectiveness (Phase 2)Looking for participantsNCT05503667
What this trial is testing

Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma Stage IIILung Adenocarcinoma Stage IVEGFR Gene Mutation
Shanghai Pulmonary Hospital, Shanghai, China 96
Testing effectiveness (Phase 2)Looking for participantsNCT06288360
What this trial is testing

Neoadjuvant Immunochemotherapy in PD-L1-negative LACC

Who this might be right for
Cervical CancerLocally Advanced Cervical CancerPD-L1 Negative+1 more
Tongji Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06219980
What this trial is testing

SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx

Who this might be right for
SBRT
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Looking for participantsNCT06424899
What this trial is testing

A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Zeng Jian 92
Testing effectiveness (Phase 2)Looking for participantsNCT06709885
What this trial is testing

HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer

Who this might be right for
Colon Adenocarcinoma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 100
Not applicableLooking for participantsNCT07111455
What this trial is testing

Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Following Neoadjuvant Chemoimmunotherapy

Who this might be right for
Locally Advanced Oral Squamous Cell Carcinoma
Zhujiang Hospital 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07346807
What this trial is testing

Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue Cancer

Who this might be right for
Tongue Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 69
Testing effectiveness (Phase 2)Looking for participantsNCT05763992
What this trial is testing

Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial

Who this might be right for
Breast CancerTriple Negative Breast CancerDietary Exposure+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 145
Not applicableStudy completedNCT06143761
What this trial is testing

Response to Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced Oral Cancer

Who this might be right for
Oral Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 206
Load More Results